Status:
COMPLETED
Sarcopenic Index and Related Factors in Patients With Type 2 Diabetes
Lead Sponsor:
Goztepe Prof Dr Suleyman Yalcın City Hospital
Conditions:
Type 2 Diabetes
Sarcopenia
Eligibility:
All Genders
40-85 years
Brief Summary
Sarcopenia, characterized by a progressive loss of skeletal muscle mass and function, is particularly common in individuals with T2DM and is often associated with insulin resistance, chronic inflammat...
Detailed Description
This study was planned retrospectively. Between September 01, 2023 and March 31, 2024, the records of patients who presented to the Diabetes Outpatient Clinic of Goztepe Prof. Dr. Suleyman Yalcin City...
Eligibility Criteria
Inclusion
- type 2 diabetes diagnosis
- with complete biochemical data on record
Exclusion
- acute infection,
- steroid use,
- acute changes in creatinine or cystatin C levels,
- recent surgery,
- limb loss.
Key Trial Info
Start Date :
July 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
839 Patients enrolled
Trial Details
Trial ID
NCT06539923
Start Date
July 1 2024
End Date
August 1 2024
Last Update
August 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SB Istanbul Goztepe Prof Dr Suleyman Yalcin City Hospital
Istanbul, Turkey (Türkiye)